Doctor profile · Federal record
Dr. Abraham Mathews, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Omaha, NE
- NPI 1568556314
- Accepts Medicare
- 42 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
6901 N 72Nd St, Suite 2244
Omaha, NE 681221709
(402) 572-3535
fax (402) 572-2688 - Mailing address
-
Po Box 641850
Omaha, NE 681647850
Credentials & registration
- NPI registered
- October 2006 — 20 yrs on file
- Profile last updated
- July 10, 2013
- Year of graduation
- 1984 — 42 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Nebraska #20876 · Iowa #32519
- Medicaid (2)
- NE #47077065413 · IA #0514661
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1568556314. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
92,148
Distinct HCPCS
10
Medicare allowed
$471,965
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 32,250 | 28 | $1 | |
J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 28,200 | 25 | $3 | |
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 11,520 | 12 | $0 | |
J9267 |
Injection, paclitaxel, 1 mg | 8,070 | 11 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 4,620 | 18 | $23 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 1,464 | 42 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,074 | 320 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 665 | 368 | $83 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 490 | 16 | $1 | |
J2405 |
Injection, ondansetron hydrochloride, per 1 mg | 480 | 17 | $0 |
In context: peer comparison
Among 16 peers in this city , average services per provider: 2,091. This provider delivers 44× the peer median.Open Payments
Industry payments received
All-time total
$316
Transactions
12
Manufacturers
9
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| PFIZER INC. | 2 | $99.78 | |
| Daiichi Sankyo Inc. | 2 | $44.67 | |
| AstraZeneca Pharmaceuticals LP | 2 | $39.42 | |
| Astellas Pharma US Inc | 1 | $30.93 | |
| Gilead Sciences, Inc. | 1 | $22.18 | |
| GENZYME CORPORATION | 1 | $22.05 | |
| SERVIER PHARMACEUTICALS LLC | 1 | $21.73 | |
| Regeneron Healthcare Solutions, Inc. | 1 | $19.92 | |
| Aveo Pharmaceuticals, Inc. | 1 | $15.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
481
Patients
77
Total drug cost
$1,332,337
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Hydroxyurea | Generic | 57 | 12 | $1,897 |
| Anastrozole | Generic | 56 | 16 | $1,577 |
| Letrozole | Generic | 54 | 13 | $1,107 |
| Dexamethasone | Generic | 44 | 25 | $1,088 |
| Imbruvica (Ibrutinib) | Brand | 29 | 0 | $506,414 |
| Prednisone | Generic | 28 | 0 | $266 |
| Eliquis (Apixaban) | Brand | 26 | 11 | $17,315 |
| Prochlorperazine Maleate | Generic | 26 | 0 | $298 |
| Acyclovir | Generic | 24 | 0 | $418 |
| Allopurinol | Generic | 24 | 0 | $300 |
Hospital affiliations
Frequently asked questions
What is Dr. Abraham Mathews's medical specialty?
Dr. Abraham Mathews practices Hematology & Oncology Physician in Omaha, NE.
Where does Dr. Abraham Mathews practice?
Dr. Abraham Mathews practices at 6901 N 72Nd St, Omaha, NE 681221709. Office phone: 4025723535.
What is Dr. Abraham Mathews's NPI?
Dr. Abraham Mathews's National Provider Identifier (NPI) is 1568556314, issued by NPPES.
Does Dr. Abraham Mathews accept Medicare assignment?
Yes. Dr. Abraham Mathews accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Abraham Mathews commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS J0881); Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101). Source: CMS Medicare Physician & Other Practitioners file.